The Exchange has sought clarification from Aarey Drugs & Pharmaceuticals Ltd on April 7, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

Aarey Drugs & Pharmaceuticals Ltd.

26 Mar 2025

56.06

1.50%

SAST

Aarey Drugs & Pharmaceuticals Ltd - 524412 - Closure of Trading Window

BSE India

Intimation for the closure of Trading window as per SEBI PIT Regulations, trading window for dealing in securities will be closed for all the officers and designated employees effective from 1st April, 2025, till 48 hours after declaration of Audited Financial results for the quarter and year ended as on 31st March, 2025

pdf

Aarey Drugs & Pharmaceuticals Ltd.

06 Mar 2025

56.06

1.50%

Company Update

AAREY DRUGS & PHARMACEUTICALS LTD. - 524412 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation regarding appointment of Company Secretary and Compliance Officer of the Company under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Aarey Drugs & Pharmaceuticals Ltd.

06 Mar 2025

56.06

1.50%

Company Update

AAREY DRUGS & PHARMACEUTICALS LTD. - 524412 - Appointment of Company Secretary and Compliance Officer

BSE India

Intimation regarding appointment of Company Secretary and Compliance Officer of the Company under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Aarey Drugs & Pharmaceuticals Ltd.

06 Mar 2025

56.06

1.50%

Corp. Note

AAREY DRUGS & PHARMACEUTICALS LTD. - 524412 - Board Meeting Outcome for Intimation Regarding Appointment Of …

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A Part A of Schedule Ill of said Regulations, we wish to inform you that, the Board of Directors of the Company, at its meeting held today i.e. Thursday, March 6, 2025 based on the recommendation of Nomination and Remuneration Committee, approved the appointment of CS Kailash Chand Jethlia(Membership No.: F1476) as Company Secretary and Compliance Officer w.e.f. March 6, 2025

pdf